C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
CNTMF Equity

CannTrust Holdings

OTCMKTS · CNTMF

$0.02
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
36/100 composite
Fundamentals26
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Fluent Corp. earns a Neutral rating with 3/5 conviction, anchored by a composite score near 36. Regulatory is the strongest pillar at 49, supported by a 50 jurisdiction posture and an 80 enforcement subscore, with no enforcement hits recorded. Market contributes 40, although the absence of an available quote limits confirmation from institutional pricing feeds. Editorial contributes 30, reflecting no identified newsroom or brief activity in CIN newsroom coverage. Fundamentals rank last at 26, constrained by weak growth, negative profitability, a low market-cap tier, and limited cash-runway support. The pillar mix places Fluent in the Neutral band: the regulatory profile provides stability, while operating performance and stretched financial condition prevent a stronger rating.

Licensed fundamentals data show year-over-year revenue contracting by roughly 22%. Gross margin stands near 19.5%, offering insufficient support against an operating margin of approximately negative 46%. Net income was a loss approaching $79 million, while EBITDA was also negative at nearly $16 million, confirming that the pressure extends beyond noncash and below-the-line items. Market capitalization is approximately $13.4 million, corresponding with a market-cap subscore near 5, and the cash-burn ratio is about 1.18. Cash runway contributes only 15 to the fundamentals assessment, consistent with the stated stretched condition. Primary regulatory filings provide no latest filing date, producing a cadence subscore of 25. No regulatory events were captured over either the latest 90-day or 180-day periods, leaving the regulatory score driven chiefly by jurisdiction posture and the clean enforcement record rather than active filing momentum.

The clearest rerating catalyst sits within the strongest pillar: restoration of a visible, consistent primary-filing cadence. A current filing would strengthen the weakest component inside regulatory, improve transparency around the severe revenue decline and operating losses, and provide a firmer basis for assessing the stretched financial position. The clean enforcement record already supplies the pillar’s principal support, but cadence now determines whether regulatory quality can translate into higher conviction. The single most important signal to watch is the appearance of a current primary regulatory filing that re-establishes consistent disclosure cadence.

Scored: 2026-09-23Valid through: 2026-11-07Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
5540 W. EXECUTIVE DRIVE, TAMPA, FL, 33609
Phone
8884415669
SEC CIK
1758124
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$13.4M
Enterprise value
$157.3M
Price to book
8.65
Price to sales
0.16
EV / EBITDA
3.63
Revenue (TTM)
$81.7M
Gross profit (TTM)
$15.9M
EBITDA
$-15.8M
Operating margin
-46.0%
Profit margin
-96.3%
Rev growth YoY
-21.9%
Return on equity
-534.2%
Return on assets
-10.3%
EPS (TTM)
$-0.16
Wall St. target price
$1.70
Shares outstanding
613.3M
Insider ownership
36.9%
Institutional ownership
1.9%
Beta
0.76
Full-time employees
826
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for CannTrust Holdings (CNTMF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for CannTrust Holdings (CNTMF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CNTMF are maintained by Cannabis Investor News and refreshed throughout the trading day.